AUSTIN, April 21, 2022--(BUSINESS WIRE)--Maxwell Biosciences ("Maxwell"), a preclinical drug platform company focused on the development of synthetic compounds that mimic biomolecules (biomimetic therapeutics), today announced the appointment of Edward Rudnic, Ph.D., as Chief Operating Officer, effective immediately. Dr. Rudnic brings more than 30 years of diverse experience in the biosciences industry.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220421005285/en/
Edward Rudnic, Ph.D. (Photo: Business Wire)
"We are pleased to welcome Ed to Maxwell Biosciences," said Maxwell CEO and Co-Founder, Joshua McClure. "As an industry veteran with extensive biotech success under his belt, we are confident that Ed will bring valuable insights, proven leadership, new patents and new chemical entities to accelerate Maxwell’s breakthrough medicines to patients."
Dr. Rudnic was the founder, chairman, and CEO of MiddleBrook Pharmaceuticals, where he raised $300M in financing and successfully brought the company public on the NASDAQ. Previously, he was the head of research and development in the U.S. at Shire Pharmaceuticals where he invented or co-invented three drug products, eventually earning the company $2 billion in annual sales. In addition, he previously held executive and leadership positions at Vivreon Biosciences, QRx Pharma, UnionBridge Management, Merck and Bristol-Myers Squibb.
"In more than 30 years in drug discovery, I’ve never seen a drug platform with the potential to benefit so many lives," says Dr. Rudnic. "With such a diverse potential for indications – from virucidal, fungicidal, and bactericidal applications, to combating cancer – all under one technology platform, Maxwell’s CLAROMER platform is unmatched. It’s a privilege to join this team of talented innovators and to join their efforts to develop novel therapies to address the unmet needs of patients globally."
Dr. Rudnic is either the lead inventor or a co-inventor of 56 issued U.S. patents and numerous related international patents. Several of his invented compounds have achieved $1 billion in revenue or greater. He is one of the most successful drug discovery executives in the industry. He holds a Bachelor of Science in Pharmacy, a Master of Science in Pharmaceutics and a Doctorate in Pharmaceutics, all from the University of Rhode Island.
About Maxwell Founded in 2016, Maxwell Biosciences is a preclinical drug platform company which develops biomimetic therapeutics – synthetic compounds that mimic and improve upon biomolecules. Inspired by nature, these low-molecular weight compounds are created by Maxwell’s exclusive first-in-class, CLAROMER™ brand drug platform and have been shown to be effective in destroying viruses, bacteria, fungi and some cancers, while safely avoiding healthy cells. These drug candidates have been shown to be well-tolerated in human tissues in vitro, and in animal studies. The compounds imitate key components of the immune system, humanity’s greatest asset in fighting disease. Maxwell’s technology is protected by granted patents and is led by a world-class team of experienced life science executives. To learn more about Maxwell Biosciences, visit MaxwellBiosciences.com, or follow us on Twitter and LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220421005285/en/
Media: Edelman for Maxwell Biosciences, Inc. MaxwellBiosciences@edelman.com
Investors: Mira Sirotic, CMA investor.relations@maxwellbiosciences.com Maxwell Biosciences, Inc.
The company will launch three Electron missions, with the first to be the inaugural launch from Launch Complex 2 in Virginia.
While Wall Street has been busy punishing the stock, which is down over 50% year to date, the total number of publications has skyrocketed. The number of papers using the company's toolset has more than tripled since the start of 2020 and is up more than 50% over the last four quarters. Maker of biotech instruments and associated consumables, 10x Genomics allows scientists to evaluate what is going on within a single cell.
Scientists who made giant strides in the fight against viral diseases and vaccine history
The new findings shed light on the early evolutionary history of feathers.
Powered by satellite data and powerful analysis models, GeoPotato is designed to enable preventive spraying, easier crop protection decisions, and improved farmer income
Europa is a prime candidate for life in the Solar System, researchers suggest.
Work on a lunar lander stalled and the loss of a program in Britain cut into the Jefferson County-based business' revenue.
Amazon's satellite venture, SpaceX's Starlink network and other satellite firms on Wednesday won a combined $278.5 million in contracts from NASA to demonstrate communications in space as the U.S. space agency moves to replace its current satellite network in orbit with privately-built systems. NASA is increasingly looking to rely on private space companies for its operations and wants to stimulate more commercial activity in areas from space communications to sending humans to orbit. Amazon's Project Kuiper, a planned network of over 3,000 satellites built to beam broadband internet to remote regions, won $67 million, while SpaceX's Starlink venture, a larger satellite-internet network with some 2,000 satellites in space already, received $70 million.
Fifth year of 3M and Ipsos global survey reveals Americans want science to help solve for sustainability, health and STEM equity challenges
Rocket Lab secures multi-launch contract with HawkEye 360 with the confirms first launch planned from Wallops Flight Facility
The discovery of ice ridges in Greenland similar to those found on Europa suggest water from the Jovian moon’s subsurface ocean could lurk near the surface.
Europa has features similar to Greenland, and they add to evidence that Jupiter's moon could support life.
NASA Awards Contracts for NOAA Lightning Mapper Phase A StudyPR NewswireGREENBELT, Md., April 20, 2022 /PRNewswire/ -- NASA has selected two firms for the Geostationary Extended Observations (GeoXO) Lightning Mapper (LMX) Phase A Study.
Congratulations and thank you to the Illumina Singapore team on having Illumina ranked #1 Best Employer in our industry, and #17 overall, in Singapore by The Straits Times!
SpaceX founder Elon Musk recently shared his vision to make trips to Mars “available to anyone” and mentioned the problems travelers could face after landing on the Red Planet. Speaking in an interview with TED Conferences’ Chris Anderson, Musk, 50, suggested that the price for a ticket to Mars could hypothetically be around $100,000. While Musk considers this cost to be in a reasonable range, he warned that early life on the Red Planet “will not be luxurious.”
They created a 3D-printed device to optimize cookie separation.
As humanity prepares to return to the Moon ("to stay," as they remind us constantly), there's a lot of infrastructure that needs to be built to make sure astronauts are safe and productive on the lunar surface. Without GPS, navigation and mapping is a lot harder — and NASA is working with lidar company Aeva to create a tool that scans the terrain when ordinary cameras and satellite instruments won't cut it. The project is called KNaCK, or Kinematic Navigation and Cartography Knapsack, and it's meant to act as a sort of hyper-accurate dead reckoning system based on simultaneous location and mapping (SLAM) concepts.
NASA is using 3D telemedicine to “teleport” doctors to the ISS. The process uses hologram technology, like Microsoft’s Hololens camera, to transport high-quality 3D models to the space station. It’s a new way that NASA is testing to help provide astronauts with the medical care that they need. NASA’s new 3D telemedicine system “teleports” doctors … The post NASA used hologram tech to ‘teleport’ a doctor onto the ISS appeared first on BGR.
NASA, Space-X Axiom-1 return delayed due to unfavorable Florida weather. Likely to cause a delay in Crew-4 launch and Crew-3 return.
Jessica Watkins will soon make history when she becomes the first Black woman to join the International Space Station for […] The post Astronaut Jessica Watkins preps for liftoff, making history with extended stay on space station appeared first on TheGrio.